As the browning of adipose tissue is hypothesized to improve insulin sensitivity and decrease weight gain, irisin has become an attractive target for potential anti-obesity therapy [4]. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.